430 related articles for article (PubMed ID: 1363356)
1. Activated oncogenes and putative tumor suppressor genes involved in human breast cancers.
Tripathy D; Benz CC
Cancer Treat Res; 1992; 63():15-60. PubMed ID: 1363356
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Gaffey MJ; Frierson HF; Williams ME
Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
[TBL] [Abstract][Full Text] [Related]
3. A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer.
Bièche I; Champème MH; Lidereau R
Cancer Res; 1994 Aug; 54(16):4274-6. PubMed ID: 7913873
[TBL] [Abstract][Full Text] [Related]
4. Oncogenesis in ovarian cancer.
Børresen AL
Acta Obstet Gynecol Scand Suppl; 1992; 155():25-30. PubMed ID: 1502889
[TBL] [Abstract][Full Text] [Related]
5. Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes.
Bergh JC
Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S20-6. PubMed ID: 2174659
[TBL] [Abstract][Full Text] [Related]
6. [Molecular analysis of breast cancers: recent developments].
Bièche I; Lidereau R
Bull Cancer; 1992; 79(12):1115-33. PubMed ID: 1304832
[TBL] [Abstract][Full Text] [Related]
7. DNA amplification at 11q13.5-q14 in human breast cancer.
Szepetowski P; Ollendorff V; Grosgeorge J; Courseaux A; Birnbaum D; Theillet C; Gaudray P
Oncogene; 1992 Dec; 7(12):2513-7. PubMed ID: 1461654
[TBL] [Abstract][Full Text] [Related]
8. Analysis of oncogenes and tumor suppressor genes in human breast cancer.
Yamashita H; Kobayashi S; Iwase H; Itoh Y; Kuzushima T; Iwata H; Itoh K; Naito A; Yamashita T; Masaoka A
Jpn J Cancer Res; 1993 Aug; 84(8):871-8. PubMed ID: 8104920
[TBL] [Abstract][Full Text] [Related]
9. Genetic studies and molecular markers of bladder cancer.
Cordon-Cardo C; Sheinfeld J; Dalbagni G
Semin Surg Oncol; 1997; 13(5):319-27. PubMed ID: 9259087
[TBL] [Abstract][Full Text] [Related]
10. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer.
Li X; Lee NK; Ye YW; Waber PG; Schweitzer C; Cheng QC; Nisen PD
J Natl Cancer Inst; 1994 Oct; 86(20):1524-9. PubMed ID: 7932807
[TBL] [Abstract][Full Text] [Related]
11. MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.
Janssen JW; Cuny M; Orsetti B; Rodriguez C; Vallés H; Bartram CR; Schuuring E; Theillet C
Int J Cancer; 2002 Dec; 102(6):608-14. PubMed ID: 12448002
[TBL] [Abstract][Full Text] [Related]
12. Suppressor genes in breast cancer: an overview.
Steeg PS
Cancer Treat Res; 1992; 61():45-57. PubMed ID: 1360244
[TBL] [Abstract][Full Text] [Related]
13. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck.
Field JK
Eur J Cancer B Oral Oncol; 1992 Jul; 28B(1):67-76. PubMed ID: 1330149
[TBL] [Abstract][Full Text] [Related]
14. Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
Børresen AL; Ottestad L; Gaustad A; Andersen TI; Heikkilä R; Jahnsen T; Tveit KM; Nesland JM
Br J Cancer; 1990 Oct; 62(4):585-90. PubMed ID: 1977466
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
16. Recessive oncogenes.
Bookstein R; Allred DC
Cancer; 1993 Feb; 71(3 Suppl):1179-86. PubMed ID: 8428341
[TBL] [Abstract][Full Text] [Related]
17. Role of proto-oncogene activation in carcinogenesis.
Anderson MW; Reynolds SH; You M; Maronpot RM
Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
[TBL] [Abstract][Full Text] [Related]
18. Amplification of the proto-oncogenes int-2, c-erb B-2 and c-myc in human breast cancer.
Machotka SV; Garrett CT; Schwartz AM; Callahan R
Clin Chim Acta; 1989 Oct; 184(3):207-17. PubMed ID: 2611995
[TBL] [Abstract][Full Text] [Related]
19. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
[TBL] [Abstract][Full Text] [Related]
20. Cellular oncogenes and suppressor genes as prognostic markers in cancer.
Duffy MJ
Clin Biochem; 1993 Dec; 26(6):439-47. PubMed ID: 8124858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]